Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKesson
QuintilesIMS
Harvard Business School
Fuji
UBS
Medtronic
Cerilliant
Express Scripts

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014715

« Back to Dashboard

NDA 014715 describes TRIAVIL 4-50, which is a drug marketed by New River and is included in one NDA. Additional details are available on the TRIAVIL 4-50 profile page.

The generic ingredient in TRIAVIL 4-50 is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 014715
Tradename:TRIAVIL 4-50
Applicant:New River
Ingredient:amitriptyline hydrochloride; perphenazine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 014715

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New River TRIAVIL 2-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
New River TRIAVIL 4-50 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-006 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
New River TRIAVIL 4-10 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
New River TRIAVIL 4-25 amitriptyline hydrochloride; perphenazine TABLET;ORAL 014715-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Deloitte
Moodys
UBS
Baxter
Fuji
Johnson and Johnson
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot